Inventors:
Kristina Allen - Hopkinton MA, US
Anthony Anisowicz - West Newton MA, US
Veronique Damagnez - Framingham MA, US
John Robinson - Downington PA, US
Paul Yaworsky - Rockland MA, US
Bheem Bhat - West Chester PA, US
International Classification:
C12Q 1/68
G01N 33/53
A61K 39/395
A61K 38/17
C07K 14/705
C07K 16/28
C07H 21/04
C12P 21/06
US Classification:
424143100, 435007100, 514012000, 435006000, 435069100, 435320100, 435325000, 530350000, 530388220, 536023500
Abstract:
The present invention provides reagents, compounds, compositions, and methods relating to novel interactions of the extracellular domain of LRP5, HBM (a variant of LRP5), and/or LRP6 with Dkk, including Dkk-1. The various nucleic acids, polypeptides, antibodies, assay methods, diagnostic methods, and methods of treatment of the present invention are related to and impact on Dkk, LRP5, LRP6, HBM, and Wnt signaling. Dkk, LRP5, LRP6, HBM, and Wnt are implicated in bone and lipid cellular signaling. Thus, the present invention provides reagents and methods for modulating lipid levels and/or bone mass and is useful in the treatment and diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis.